Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 93 is a human pseudogene that shares sequence similarity with the 7SK small nuclear RNA gene (RN7SK), which is an abundant non-coding RNA involved in the regulation of transcription elongation by controlling the activity of the positive transcription elongation factor P-TEFb[4][3][5]. Unlike the functional RN7SK gene, RN7SKP93 is annotated as a pseudogene and is not known to produce a functional RNA or participate in recognizable biological processes. There are no known roles for RN7SKP93 in disease, no documented interactions with drugs, and it is not considered a therapeutic target. Its listing in gene catalogs serves primarily as a genomic annotation rather than as an entity with functional or clinical relevance[5][8][9]. RN7SK pseudogene 93 is a pseudogene without a known biological function, disease role, or utility as a therapeutic target. Its inclusion in genomic resources is for annotation purposes only.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 93 (RN7SKP93).